The importance of monitoring prostate and hematocrit  

  RSS

guijr
(@guijr)
Estimable Member
Joined: 5 months  ago
Posts: 234
07/11/2018 12:42 pm  

Just to reinforce the importance of blood work and other specific exams in order to detect prostate events and elevated hematocrit. So periodic evaluation of hematocrit, PSA and digital rectal examination of the prostateis is key to monitor (and MANAGE) any testosterone-related side effects. IMO, better safe than sorry.

=============================

Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S. Adverse events associated with Testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci. 2005;60(11):1451-7.

ABSTRACT

BACKGROUND: We performed a meta-analysis of randomized clinical trials to determine the risks of adverse events associated with testosterone replacement in older men. METHODS: The MEDLINE database was searched from 1966 to April 2004, using testosterone as the indexing term; limits included human, male, >/=45 years old, and randomized controlled trial. Of the 417 studies thus identified, 19 met the inclusion criteria: testosterone replacement for at least 90 days, men >/=45 years old with low or low-normal testosterone level, randomized controlled trial, and medically stable men. Odds ratios (ORs) were pooled using a random effects model, assuming heterogeneous results across studies, and were weighted for sample size. RESULTS: In the 19 studies that met eligibility criteria, 651 men were treated with testosterone and 433 with placebo. The combined rate of all prostate events was significantly greater in testosterone-treated men than in placebo-treated men (OR = 1.78, 95% confidence interval [CI], 1.07-2.95). Rates of prostate cancer, prostate-specific antigen (PSA) >4 ng/ml, and prostate biopsies were numerically higher in the testosterone group than in the placebo group, although differences between the groups were not individually statistically significant. Testosterone-treated men were nearly four times as likely to have hematocrit >50% as placebo-treated men (OR = 3.69, 95% CI, 1.82-7.51). The frequency of cardiovascular events, sleep apnea or death was not significantly different between the two groups. CONCLUSIONS: Testosterone replacement in older men was associated with a significantly higher risk of detection of prostate events and of hematocrit >50% than was placebo; hematocrit increase was the most frequent adverse event associated with testosterone replacement. These data reaffirm the need to monitor hematocrit, PSA, and digital examination of the prostate during testosterone replacement in older men.

"The medals don't mean anything and the glory doesn't last. It's all about your happiness. The rewards are going to come, but my happiness is just loving the sport and having fun performing" ~ Jackie Joyner Kersee.


ReplyQuote
liftsiron
(@liftsiron)
Estimable Member
Joined: 5 months  ago
Posts: 197
07/11/2018 1:23 pm  

My last psa was .9.

liftsiron is a fictional character and should be taken as such.


ReplyQuote
D-Termined
(@d-termined)
Active Member
Joined: 5 months  ago
Posts: 12
07/11/2018 1:58 pm  

Along with the blood work, its probably not a bad idea to jump on some Saw palmetto, and for extra precausion, jump on some Pygeum, and maybe some pumpkin seed extract. Especially if older and on some good ole T

D


ReplyQuote
Share:
  
Working

Please Login or Register